Elantas Beck India informs about outcome of board meeting

20 Feb 2024 Evaluate
Elantas Beck India has informed that the Board of Directors of the Company at its meeting held on Tuesday, 20th February,2024, has, approved and taken on record- The Audited Financial Results (Standalone) for the quarter and financial year ended 31st December, 2023 along with segment-wise financial results and the reports of Auditors thereon pursuant to regulation 33 of SEBI Listing Regulations. The copy of aforesaid results along with audit report of the statutory auditors’ and a declaration in respect of unmodified opinion by statutory auditors’ is enclosed; Recommended a final dividend of Rs 5 per fully paid-up equity shares of Rs 10 each (face value), for the financial year ended 31st December, 2023, subject to deduction of tax, as applicable and approval of Members at the ensuing sixty-eighth Annual General Meeting. Further details enclosed.

The above information is a part of company’s filings submitted to BSE.

Elantas Beck India Share Price

11450.00 736.00 (6.87%)
30-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Tata Chemicals 1072.30
SRF 2619.15
Pidilite Inds. 3045.00
Aarti Inds 742.20
Gujarat Fluorochemic 3616.20
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.